Caplin Steriles Gets USFDA Approval for $71M Drug

Caplin Steriles Limited received final USFDA approval for its generic Calcium Gluconate Injection in three vial sizes.
The approved drug addresses a US market with annual sales of approximately $71 million as of March 2026.
This marks the 54th ANDA approval for the sterile injectables subsidiary of Caplin Point Laboratories.